Información de la revista
Review articles
Developments in urologic oncology “OncoForum”: The best of 2016
F. Gómez-Veiga, A. Alcaraz-Asensio, J. Burgos-Revilla, J.M. Cózar-Olmo
Actas Urol Esp. 2017;41:543-51
Small-caliber percutaneous nephrolithotomy (SC-PCNL). Therapeutic decision algorithm
J.H. Amón Sesmero, M. Cepeda Delgado, B. de la Cruz Martín, J.A. Mainez Rodriguez, D. Alonso Fernández, V. Rodriguez Tesedo, D.A. Martín Way, J. Gutiérrez Aceves
Actas Urol Esp. 2017;41:552-61
Commentary
Comment to: “Management and follow-up of the male with lower urinary tract symptoms secondary to benign prostate hyperplasia”
A. Alcántara Montero
Actas Urol Esp. 2017;41:562-3
Original articles
Risk models for patients with localized renal cell carcinoma
J.M. Velis, F.J. Ancizu, M. Hevia, I. Merino, A. García, P. Doménech, R. Algarra, A. Tienza, ... J.E. Robles
Actas Urol Esp. 2017;41:564-70
Prognostic factors for vesical relapse in patients with upper urothelium tumours treated with surgery
J. Aragón Chamizo, F. Herranz Amo, C. Hernández Fernández, C. González Enguita
Actas Urol Esp. 2017;41:571-6
Usefulness of GATA-3 as a marker of seminal epithelium in prostate biopsies
J.A. Ortiz-Rey, D. Chantada-de la Fuente, M.Á. Peteiro-Cancelo, C. Gómez-de María, M.P. San Miguel-Fraile
Actas Urol Esp. 2017;41:577-83
Shockwave lithotripsy with music: Less painful and more satisfactory treatment
D.G. Ordaz Jurado, A. Budia Alba, P. Bahilo Mateu, M. Trassierra Villa, D. López-Acón, F. Boronat Tormo
Actas Urol Esp. 2017;41:584-9
Casuistry
Adjuvant intravesical treatment for non-muscle invasive bladder cancer: The importance of the strain and maintenance
F. Guerrero-Ramos, A. Lara-Isla, J. Justo-Quintas, J.M. Duarte-Ojeda, F. de la Rosa-Kehrmann, F. Villacampa-Aubá
Actas Urol Esp. 2017;41:590-5
Diagnostic yield of lumbosacral magnetic resonance imaging requested by pediatric urology consultations
M. Fernández-Ibieta, J. Rojas Ticona, V. Villamil, M.J. Guirao Piñera, A. López García, G. Zambudio Carmona
Actas Urol Esp. 2017;41:596-601
Letters to the editor
Sodium glucose cotransporter 2 inhibitors and males lower urinary tract symptoms, an aspect to consider
A. Alcántara Montero
Actas Urol Esp. 2017;41:602
Primary signet ring cell carcinoma of the prostate with response to abiraterone
F. Sáez Barranquero, B. Herrera Imbroda
Actas Urol Esp. 2017;41:603-4